[Changes in mucopolysaccharides and ultrastructural alterations in experimental atheromatosis].
D000818:Animals; D001011:Aorta / Q000648:ultrastructure; D001161:Arteriosclerosis / Q000378:metabolism / Q000473:pathology*; D001241:Aspirin / Q000494:pharmacology; D004036:Diet, Atherogenic; D004176:Dipyridamole / Q000494:pharmacology; D004727:Endothelium / Q000648:ultrastructure; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006025:Glycosaminoglycans / Q000378:metabolism*; D011817:Rabbits; D014148:Tranexamic Acid / Q000494:pharmacology; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology
D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; D004176:Dipyridamole; D014148:Tranexamic Acid; D014568:Urokinase-Type Plasminogen Activator; D001241:Aspirin
Modificaciones de los mucopolisacáridos y alteraciones ultraestructurales en la ateromatosis experimental.